300676 华大基因
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)0.9328.27819.19540.8906.518
总资产报酬率 ROA (%)0.6645.60611.48624.4424.952
投入资产回报率 ROIC (%)0.7766.45113.70122.3336.159

边际利润分析
销售毛利率 (%)49.90352.27358.09460.07053.559
营业利润率 (%)3.46315.42426.94129.75011.789
息税前利润/营业总收入 (%)1.60114.15527.34431.61911.485
净利润/营业总收入 (%)2.15411.47421.84025.0339.946

收益指标分析
经营活动净收益/利润总额(%)206.610115.02096.795104.346110.770
价值变动净收益/利润总额(%)-28.62638.56014.9056.2785.645
营业外收支净额/利润总额(%)-30.392-8.057-4.407-2.288-0.592

偿债能力分析
流动比率 (X)2.4062.4713.2612.2142.824
速动比率 (X)2.2232.2903.0021.9482.521
资产负债率 (%)26.51128.94533.76446.17525.521
带息债务/全部投入资本 (%)14.78616.16119.847--1.276
股东权益/带息债务 (%)570.761508.284372.023282.1887,120.101
股东权益/负债合计 (%)273.186242.000193.619114.331286.062
利息保障倍数 (X)-1.518-118.56117.74512.478-49.046

营运能力分析
应收账款周转天数 (天)151.33587.48173.8150.000159.586
存货周转天数 (天)109.04185.318119.8260.00080.949